Isis Pharmaceuticals (ISIS) To Receive $10M from OncoGenex (OGXI) and Teva (TEVA) OGX-011 Licensing Agreement
Tweet Send to a Friend
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
